| Controls | PCOS | ||
---|---|---|---|---|
H1H1 (n = 318) | H1H2 + H2H2 (n = 163 + 25) | H1H1 (n = 370) | H1H2 + H2H2 (n = 177 + 28) | |
Age (yr) | 28.17 ± 4.17 | 27.56 ± 4.21 | 24.68 ± 4.03a, b | 24.63 ± 3.84a, b |
BMI (kg/m2) | 21.18 ± 2.95 | 20.91 ± 2.81 | 22.94 ± 4.23a, b | 23.41 ± 4.29a, b |
Waist circumference (cm) | 73.36 ± 7.96 | 73.35 ± 8.61 | 79.35 ± 11.36a, b | 80.06 ± 12.02a, b |
Waist-to-hip ratio | 0.81 ± 0.06 | 0.82 ± 0.06 | 0.85 ± 0.07a, b | 0.85 ± 0.08a, b |
F-G score | 0.25 ± 0.76 | 0.19 ± 0.68 | 1.77 ± 2.06a, b | 1.63 ± 2.10a, b |
Acne grade score | 0.11 ± 0.31 | 0.07 ± 0.26 | 0.68 ± 0.96 a, b | 0.52 ± 0.86a, b, c |
SBP (mmHg) | 113.32 ± 11.26 | 113.32 ± 12.22 | 114.36 ± 10.43a | 115.08 ± 11.27a |
DBP (mmHg) | 73.81 ± 8.89 | 73.78 ± 8.76 | 76.27 ± 9.08a, b | 75.38 ± 9.06a |
Ovarian volume (ml) | 7.80 ± 2.86 | 7.71 ± 2.99 | 10.15 ± 3.99a, b | 10.15 ± 4.32a, b |
Hormonal levels | ||||
E2 (pmol/L) | 324.35 ± 341.91 | 349.79 ± 366.62 | 283.87 ± 285.58 | 284.41 ± 244.71 |
TT (nmol/L) | 1.55 ± 0.53 | 1.52 ± 0.56 | 2.41 ± 0.77a, b | 2.43 ± 0.77a, b |
LH (IU/L) | 8.80 ± 11.33 | 8.61 ± 11.40 | 13.65 ± 9.01a, b | 14.33 ± 13.68a, b |
FSH (IU/L) | 6.64 ± 3.02 | 6.71 ± 2.92 | 5.94 ± 1.89a, b | 6.08 ± 2.74a, b |
LH/FSH | 1.32 ± 1.26 | 1.28 ± 1.41 | 2.32 ± 1.20a, b | 2.42 ± 1.36a, b |
Metabolic profile | ||||
Fasting Ins (pmol/L) | 65.53 ± 34.31 | 69.27 ± 40.51 | 105.28 ± 75.66a, b | 107.54 ± 71.75a, b |
Fasting Glu (mmol/L) | 5.27 ± 0.44 | 5.35 ± 1.06 | 5.39 ± 0.84a | 5.35 ± 0.62 |
HOMA-IR | 2.24 ± 1.27 | 2.51 ± 2.64 | 3.80 ± 3.40a, b | 3.77 ± 2.79a, b |
TG (mmol/L) | 1.03 ± 1.00 | 1.05 ± 0.68 | 1.41 ± 1.47a, b | 1.45 ± 1.13a, b |
TC (mmol/L) | 4.30 ± 0.68 | 4.15 ± 0.72a | 4.41 ± 0.81a, b | 4.39 ± 0.82b |
HDL-C (mmol/L) | 1.52 ± 0.32 | 1.49 ± 0.31 | 1.39 ± 0.34a, b | 1.37 ± 0.35a, b |
LDL-C (mmol/L) | 2.41 ± 0.57 | 2.26 ± 0.66a | 2.57 ± 0.76a, b | 2.51 ± 0.77a, b |
non-HDL-C (mmol/L) | 2.78 ± 0.60 | 2.66 ± 0.70 | 3.03 ± 0.82a, b | 3.02 ± 0.80a, b |
AI | 1.92 ± 0.65 | 1.88 ± 0.73 | 2.37 ± 1.03a, b | 2.37 ± 1.00a, b |
ApoA1 (g/L) | 1.46 ± 0.22 | 1.44 ± 0.19 | 1.42 ± 0.21a | 1.41 ± 0.22a, b |
ApoB (g/L) | 0.76 ± 0.15 | 0.73 ± 0.18 | 0.83 ± 0.21a, b | 0.81 ± 0.20a, b |
ApoB/apoA1 | 0.53 ± 0.13 | 0.52 ± 0.17 | 0.60 ± 0.18a, b | 0.59 ± 0.18a, b |
PAF-AH activityd | ||||
Plasma PAF-AH (nmol/min/ml) | 49.20 ± 10.27 | 47.20 ± 11.50 | 48.01 ± 12.50 | 46.39 ± 13.71 |
H-PAF-AH (nmol/min/ml) | 5.12 ± 1.46 | 5.17 ± 1.59 | 4.61 ± 1.98a, b | 4.76 ± 1.80 |
ApoB-PAF-AH (nmol/min/ml) | 44.08 ± 9.40 | 42.03 ± 10.67 | 43.39 ± 11.49 | 41.63 ± 12.56 |
ApoB-PAF-AH/H-PAF-AH | 9.07 ± 2.59 | 8.55 ± 2.29 | 10.42 ± 4.37a, b | 9.33 ± 2.69c |